Professional Documents
Culture Documents
Page 1 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
1.1 Background
The LATAM NextGen CRM technology provider will be responsible for providing the
software and licensing for a sales force automation product that will allow Novo Nordisk
field representatives to effectively manage their activities in the field. The vendor will be
responsible for data security, data privacy, periodic audits, and any other regulatory
aspect that Novo Nordisk may consider suitable.
The LATAM NextGen CRM solution will need to accommodate approximately 600 users
across Latin American field teams. The volume may increase or decrease depending on
Novo Nordisk’s future business growth which could include global affiliates in Novo
Nordisk A/S and the solution must be able to cope with such changes.
Page 2 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
System Description
IO Data Lake - vIctOria Corporate IT Big Data Platform – OASIS based on Amazon Web
Services (AWS) which acts as an integration backbone for CRM
and reporting tools with QlikSense as the preferred BI
technology
IO SELAS (Sales CRM system for call planning and reporting for the sales force
Excellence Leveraging
Automation Software)
IO MAX (Market Access) CRM system for Market Access and Public Affairs based on IO
SELAS
IO MATT (Medical CRM system for Medical to manage their activities based on IO
Activities Tracking Tool) SELAS
IO SOMS (Sample Order System to manage orders for samples from customers.
Management System) Additional local systems also exist
IO Coaching System used by field sales managers to coach the sales reps in
their teams
iSelling iPad application which hosts visual aids for e-Detailing based on
Adobe AEM/CQ5 platform
The figure below depicts an illustrative view of the architecture landscape as a reference.
It may not represent all the interfaces that the existing application currently supports.
Novo Nordisk is looking for proposed solutions that address the interfaces of all existing
systems and more in the future as our business evolves.
Page 3 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
Current setup has IO SELAS system as the CRM system. It interacts with mobility and
reporting platforms. In addition, there are satellite systems which extract customer
information from IO SELAS database. In some instances, updates to data such as call
plan & territory are handled in these satellite systems and uploaded to IO SELAS system
using an excel sheet.
Page 4 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
Page 5 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
1.5 Scope
Design, configure and build new CRM system
Design and build of all inbound and outbound interfaces
System and Integration Test (SIT)
Support User Acceptance Test (UAT)
Data migration
Environment management (e.g. preparing a test or training environment with
configuration and data or performing environment refreshes)
Deployment in production and test/sanity checks (technical go-live) including initial
data loads (e.g. call plans or territories)
Training materials and train-the-trainer session
Full rollout to all affiliates (business go-lives)
Handover to System Management
Hyper care
Warranty on defects
Page 6 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
2. Project Approach
The project follows the Novo Nordisk IT Project Management Methodology (ITPMM). ITPMM
builds on Novo Nordisk best practices for managing IT projects and it defines five phases
with decision Gates and Mandatory Output:
The project is currently in the INITIATE project phase where focus is at:
This overall approach is designed to allow the project to front-load business and/or technical
challenges before final project planning is completed and G3 is approved, permitting the
project to focus on Change Management, system roll out and establishment of system
management organisation, while system implementation and qualification are executed.
The project is proposing to take an iterative implementation approach where the Supplier
and Novo Nordisk project team work in close collaboration; designing the solution based on
workshops and where requirements are defined via solution demos and Novo Nordisk
process owners define/clarify the business processes. This way Novo Nordisk processes are
defined, harmonised, build and tested in sprints as part of an iterative process with clear
design and project milestones. This goes for both Analyse and Execute phase.
Novo Nordisk is simply proposing the above mentioned working approach, but requests the
Supplier to describe the implementation approach recommended by the Supplier. It is
expected that the Supplier will have industry best practices and in-depth knowledge on the
best approach for similar projects.
The project will be divided into an Analyse phase with a prototype and an
Execute/Implementation/Roll-out phase that will focus on building and rolling out the
functional scope as depicted in the three proposed phases outlined in Figure 5: Proposed
phases and functional scope.
Page 7 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
Execute/Implementation/Roll-out:
o Following the Analyse phase, Novo Nordisk envisions to implement the
solution in 3 phases (see Figure 5: Proposed phases and functional scope).
o Once Phase I is technical live Novo Nordisk would like to conduct a small pilot
with end-users to capture essential feedback regarding the solution and test
assumptions before full roll out.
Page 8 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
The exact scope and timing of each Phase (as depicted in Figure 5: Proposed phases and
functional scope) will be adjusted during the Analyse phase based on business priorities,
Supplier advice and industry best practices. At G3 Supplier and Novo Nordisk must have an
agreement on the phased approach.
The proposed phases and functional scope outlined above are the result of internal Novo
Nordisk analysis of our current CRM maturity, tool usage and affiliate experience. It was
assessed that the maturity is higher within basic Sales CRM processes, while more advanced
processed like Events, KOL Engagement and Key Account Management were less mature.
To ensure an ambitious, yet realistic scope, the StC has decided to move Medical and MAPA
to phase II. If phase I is progressing as expected and the business is ready, Novo Nordisk
would like to have the flexibility to move forward the initiation of Phase II and III, please
describe the Supplier conditions/assumptions for how to handle this flexibility.
Novo Nordisk encourages the Supplier to propose alternative scope/phased approach and
relevant preparation activities for phase II/III during Phase I. It is important that Novo
Nordisk resources, role and effort required are clearly outlined so that the right decision can
be taken by relevant Novo Nordisk stakeholders.
Page 9 of 10
REQUEST FOR PROPOSAL LATAM NextGen CRM
--END—
Page 10 of 10